₹74.00
-0.97 (-1.29%)
As of 23 Sept 2026, Concord Drugs Ltd share price is ₹74.00. The stock opened at ₹74.00 and had closed at ₹74.97 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹61.00 and a high of ₹92.52. In terms of performance, Concord Drugs Ltd share price has increased by 2.73% over the past six months and has increased by 12.12% over the last year.
Concord Drugs Stock Price Chart
Concord Drugs Ltd Overview
Market cap₹98 Crs
Volume9,775
Prev. Close₹74.97
Year range₹61.00 - ₹92.52
ISININE858L01010
About Concord Drugs
Concord Drugs is to manufacture licensed drugs based on the formulations approved.
Concord Drugs Ltd Historical Performance
1 Month Return-1.33%
6 Month Return0.00%
3 Year Return119.65%
3 Month Return-2.80%
1 Year Return10.45%
5 Year Return141.44%
Concord Drugs Ltd Fundamentals
ROCE(TTM)4.82%
P/E Ratio (TTM)47.74
P/B Ratio2.09
Debt to Equity0.24
ROE2.14%
EPS (TTM)1.55
Dividend Yield0.00%
Book Value35.43
Profit Margin2.45%
Operating Margin5.05%
Concord Drugs Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 75.88 | 36.94 | 43.27 | 51.32 | 59.06 |
| EBITDA | 4.27 | 3.78 | 3.69 | 4.35 | 5.69 |
| Net Profit | 1.04 | 0.30 | 0.42 | 0.89 | 1.59 |
| EPS | 0.93 | 0.30 | 0.42 | 0.96 | 1.82 |
Concord Drugs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 72.80 |
| Resistance 1 (R1) | 77.55 |
| Pivot Point | 75.37 |
Concord Drugs Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| S Nagi Reddy | Chairman |
| Koni Reddy | Chief Financial Officer |
| S. Manoj Kumar Reddy | WTD & Executive Directorector |
Concord Drugs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,846.40-1.20% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,352.00-0.62% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,935.00-0.70% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Concord Drugs Ltd today is ₹74.00 on NSE and ₹74.00 on BSE.
- The 52-week high of Concord Drugs Ltd is ₹92.52, while the 52-week low is ₹61.00.
- The current market capitalisation of Concord Drugs Ltd is approximately ₹98 crore.
- The P/E (Price-to-Earnings) ratio of Concord Drugs Ltd is 126.33. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Concord Drugs Ltd is 2.09. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Concord Drugs Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Concord Drugs on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Concord Drugs Ltd has delivered a return of approximately 119.65%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Concord Drugs Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 45.08% promoters, 0.00% FIIs, 0.00% DIIs, and 54.19% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
